A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder

Journal of Psychopharmacology

Volumn 24, Issue 8, 2010, Pages 1175-1181

  Mathew, S J ^a   Price, R B ^a,b   Shungu, D C ^c   Mao, X ^c   Smith, E L P ^d   Amiel, J M ^e   Coplan, J D ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e College of Physicians and Surgeons ^*  (United States)

Author keywords

generalized anxiety disorder; N acetylaspartate; paroxetine; proton magnetic resonance spectroscopy

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID; PAROXETINE;

ADULT; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HIPPOCAMPUS; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REMISSION; TREATMENT OUTCOME;

ADULT; ANXIETY DISORDERS; ASPARTIC ACID; CREATINE; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEURONS; PAROXETINE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955149101     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108101796     Document Type: Article

References (26)

1. Akiskal, HS (1998) Toward a definition of generalized anxiety disorder as an anxious temperament type. Acta Psychiatr Scand 393: 66-73.
2. Barker, PB (2001) N-acetyl aspartate-a neuronal marker. Ann Neurol 49: 423-424.
3. Barlow, DH (2002) Anxiety and its Disorders: The Nature and Treatment of Anxiety and Panic, second ed. New York: Guilford Press.
4. Baslow, MH (2003) N-acetylaspartate in the vertebrate brain: Metabolism and function. Neurochemical Res 28: 941-953.
5. Bertolino, A., Callicott, JH, Nawroz, S., Mattay, VS, Duyn, JH, Tedeschi, G., et al. (1998) Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. Neuropsychopharmacol 18: 1-9. (Pubitemid 28116368)
6. Blair, K., Shaywitz, J., Smith, BW, Rhodes, R., Geraci, M., Jones, M., et al. (2008) Response to emotional expressions in generalized social phobia and generalized anxiety disorder: evidence for separate disorders. Am J Psychiatry 165: 1193-1202.
7. Bremner, JD, Mletzko, T., Welter, S., Quinn, S., Williams, C., Brummer, M., et al. (2005) Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study. J Psychopharmacol 19: 159-165.
8. Bremner, JD, Vermetten, E., Mazure, CM (2000) Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: the Early Trauma Inventory. Depress Anxiety 12: 1-12.
9. Duyn, JH, Gillen, J., Sobering, G., van Zijl, PCM, Moonen, CTW (1993) Multisection proton MR spectroscopic imaging of the brain. Radiology 188: 277-282.
10. First, MB, Spitzer, RL, Gibbon, M., Williams, JBW (1995) Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition, Version 2. New York: New York State Psychiatric Institute.
11. Freeman, TW, Cardwell, D., Karson, CN, Komoroski, RA (1998) In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. Magn Reson Med 40: 66-71.
12. Ham, BJ, Chey, J., Yoon, SJ, Sung, Y., Jeong, DU, Ju Kim, S., et al. (2007) Decreased N-acetyl-aspartate levels in anterior cingulate and hippocampus in subjects with post-traumatic stress disorder: A proton magnetic resonance spectroscopy study. Eur J Neurosci 25: 324-329. (Pubitemid 46096246)
13. Jang, JH, Kwon, JS, Jang, DP, Moon, WJ, Lee, JM, Ha, TH, et al. (2006) A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder. Am J Psychiat 163: 1202-1207.
14. Lyoo, IK, Renshaw, PF (2002) Magnetic resonance spectroscopy: current and future applications in psychiatric research. Biol Psychiatry 51: 195-207.
15. Mathew, SJ, Mao, X., Coplan, JD, Smith, ELP, Sackeim, HA, Gorman, JM, et al. (2004) Dorsolateral prefrontal cortical neuronal pathology in adult generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study. Am J Psychiatry 161: 1119-1121.
16. Mathew, SJ, Price, RB, Mao, X., Smith, ELP, Coplan, JD, Charney, DS, et al. (2008) Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder. Biol Psychiatry 63: 891-898.
17. Risterucci, C., Coccurello, R., Banasr, M., Stutzmann, JM, Amalric, M., Nieoullon, A. (2006) The metabotropic glutamate receptor subtype 5 antagonist MPEP and the Na+ channel blocker riluzole show different neuroprotective profiles in reversing behavioral deficits induced by excitotoxic prefrontal cortex lesions. Neuroscience 137: 211-220.
18. Rosenberg, DR, MacMaster, FP, Keshavan, MS, Fitzgerald, KD, Stewart, CM, Moore, GJ (2000) Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 39: 1096-1103.
19. Sairanen, M., OLeary, OF, Knuuttila, JE, Castrén, E. (2007) Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience 144: 368-374.
20. Sanacora, G., Mason, GF, Rothman, DL, Krystal, JH (2002) Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159: 663-665.
21. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809.
22. Sapolsky, RM (2000) The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death. Biol Psychiatry 48: 755-765.
23. Schuff, N., Neylan, TC, Lenoci, MA, Du, AT, Weiss, DS, Marmar, CR, et al. (2001) Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry 50: 952-959.
24. Tiraboschi, E., Tardito, D., Kasahara, J., Moraschi, S., Pruneri, P., Gennarelli, M., et al. (2004) Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacol 29: 1831-1840.
25. Vermetten, E., Vythilingam, M., Southwick, SM, Charney, DS, Bremner, JD (2003) Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol Psychiatry 54: 693-702.
26. Wang, JW, David, DJ, Monckton, JE, Battaglia, F., Hen, R. (2008) Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci 28: 1374-1384.